SCHEMBL26211640

SCHEMBL26211640

CCC(CCCCCC(=O)OCc1ccccc1)CCCCCC(=O)OCc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.49
MEN1 O00255 1/20 0.49
HPGD P15428 1/20 0.49
KMT2A Q03164 1/20 0.49
MAPK1 P28482 2/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
CYP3A4 P08684 3/20 0.48
TSHR P16473 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
ATM Q13315 1/20 0.48
PRSS1 P07477 1/20 0.47
PRSS2 P07478 1/20 0.47
PRSS3 P35030 1/20 0.47
EPHX2 P34913 1/20 0.46
LMNA P02545 1/20 0.45
SIRT2 Q8IXJ6 3/20 0.44
SIRT1 Q96EB6 2/20 0.44
SIRT3 Q9NTG7 1/20 0.43
HDAC3 O15379 1/20 0.43
HDAC4 P56524 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14672533 0.88 CYP3A4 (0.68) ALDH1A1MEN1HPGDKMT2AMAPK1
SCHEMBL14672346 0.88 CYP3A4 (0.68) ALDH1A1MEN1HPGDKMT2AMAPK1
SCHEMBL7878024 0.88 ALDH1A1 (0.54) ALDH1A1MEN1HPGDKMT2AMAPK1
SCHEMBL20943379 0.87 ALDH1A1 (0.50) ALDH1A1MEN1HPGDKMT2AMAPK1
SCHEMBL20943301 0.87 ALDH1A1 (0.50) ALDH1A1MEN1HPGDKMT2AMAPK1
SCHEMBL3683407 0.87 CYP3A4 (0.69) ALDH1A1MEN1HPGDKMT2AMAPK1
SCHEMBL20943402 0.87 MEN1 (0.54) ALDH1A1MEN1HPGDKMT2APRSS1
SCHEMBL20943310 0.87 MEN1 (0.54) ALDH1A1MEN1HPGDKMT2APRSS1
SCHEMBL24733316 0.86 SLC15A1 (0.49) ALDH1A1MEN1HPGDKMT2AMAPK1
SCHEMBL22465659 0.85 ALDH1A1 (0.51) ALDH1A1MEN1HPGDKMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230286902-A1 LIPID NANOPARTICLE COMPOSITION Suzhou Abogen Biosciences Co., Ltd. (CN) 2023-09-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230286902-A1 LIPID NANOPARTICLE COMPOSITION CETP, NPC1, LCAT ALDH1A1 4587/4885MEN1 2081/4885HPGD 2816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.